Shares of Heart Test Laboratories, Inc. (NASDAQ:HSCS – Get Free Report) dropped 13% during mid-day trading on Tuesday . The company traded as low as $2.36 and last traded at $2.48. Approximately 41,383 shares traded hands during trading, a decline of 13% from the average daily volume of 47,512 shares. The stock had previously closed at $2.85.
Heart Test Laboratories Stock Performance
The firm has a market cap of $1.83 million, a price-to-earnings ratio of -0.06 and a beta of 3.13. The business has a 50 day simple moving average of $3.56 and a 200-day simple moving average of $7.08.
Heart Test Laboratories Company Profile
Heart Test Laboratories, Inc, a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals.
Featured Stories
- Five stocks we like better than Heart Test Laboratories
- Top Stocks Investing in 5G Technology
- 3 Leveraged ETFs to Multiply Returns
- Insider Selling Explained: Can it Inform Your Investing Choices?
- A Tale of Two Titans: Unveiling the Value in Baidu and JD.com
- How to Invest in Blue Chip Stocks
- Is the AI-Capable iPhone 16 the Start of a Sales Super-Cycle?
Receive News & Ratings for Heart Test Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heart Test Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
